What's new in treatment for relapsing remitting ms

Stay tuned: Stay tuned! this field is changing rapidly. Whereas injectable medications are the first tier of therapy, we are entering an era of oral medications and infrequent infusion therapies. Choosing the right therapy from this more and more crowded field of contenders will only get more complex. An MS specialist can help guide the discussion so that individuals can make the best informed choice.

Multiple sclerosis : The latest treatment for relapsing remitting multiple sclerosis is the long awaited tecfidera (dimethyl fumerate) also known as bg12. This is an oral therapy twice a day with one week titration and little monitoring involved. Offers near 50% reduction in relapse rate.

A few items: Research in progressive MS is ongoing, and best potential for Gilenya or Tysabri, (natalizumab) but not yet clear. Aubagio might have promise to control earliest onset (CIS). Newest drug for R/R is Tecfidera, and Lemtrada is likely to emerge on market late this year. Research on ocrelizamab, laquinamod, daclizamab, and a new Plegridy injection also new. The latest Copaxone at thrice weekly injection is here

Many are coming out: There are many new treatments coming out soon. What is new depends on what you know. Longer-acting injections and oral medicines are fairly new. Here is a link to more information: http://www.neurocuro.com/medicines-used-to-treat-ms/